Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Published on by World Top Scientists

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Published on by World Top Scientists

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Georgiana Zaharia | Health Professions | Women Researcher Award

Published on by World Top Scientists

Mrs. Georgiana Zaharia | Health Professions | Women Researcher Award

Estudiante de Doctorado at UNIVERSITARIOS DE VALENCIA (UV) , Spain

Georgiana Zaharia Hamza is an accomplished Clinical Research Nurse and Study Coordinator with a passion for improving patient outcomes through innovative and evidence-based healthcare practices. Currently based at Hospital Clínico Universitario de Valencia, she has cultivated a strong foundation in coordinating cardiology clinical trials and providing high-quality patient care. Georgiana is recognized for her meticulous attention to clinical protocols, robust knowledge of Good Clinical Practice (GCP) guidelines, and her ability to bridge the gap between clinical implementation and academic research. Multilingual and culturally adaptable, she brings valuable international perspective to her work, with native fluency in Spanish, Romanian, and Valencian, and professional proficiency in English and French. Alongside her research activities, she contributes to academia as a substitute professor at the University of Valencia, where she instructs future healthcare professionals in critical subjects such as Women’s Health and Clinical Research. Her career reflects dedication, empathy, and excellence in clinical and academic healthcare.

Professional Profile

Education

Georgiana’s academic journey reflects her deep commitment to advancing nursing and clinical research. She is currently pursuing a PhD in Nursing at the University of Valencia, where her research explores the therapeutic use of music as an intervention to reduce loneliness in community-dwelling individuals — a project that blends clinical knowledge with compassionate care. She holds two master’s degrees: one in Clinical Trial Monitoring and Pharmaceutical Development from the University of Nebrija and INESEM Business School (2022–2023), which equipped her with skills in trial design and regulatory affairs, and another in the Deterioration of Cutaneous Integrity, Ulcers, and Wounds from the Catholic University of Valencia (2021–2022), reflecting her clinical specialization. Georgiana has also completed key certifications such as ICH-GCP and IATA Dangerous Goods Transport, demonstrating her compliance with international research standards. Her diverse education bridges clinical practice, research design, and innovation in patient care.

Professional Experience

Georgiana has built a dynamic and progressive career in healthcare and research. Since 2021, she has worked as a Clinical Research Nurse and Study Coordinator at Hospital Clínico Universitario de Valencia, managing cardiology clinical trials and ensuring high standards of protocol adherence and data integrity. She is proficient in electronic data capture systems such as Redcap, Medidata Rave, and Mizar, which are critical for real-time data collection and monitoring. She also has hands-on nursing experience in the hospital’s electrophysiology department, providing direct care to patients undergoing complex cardiac procedures. Her academic role as a substitute professor at the University of Valencia highlights her leadership in nursing education, where she designs and delivers lectures on Physiology, Pathophysiology, and Women’s Health. Additionally, Georgiana contributed to research on nutrition and mental health during her time as a Research Collaborator at the University of Valencia (2020–2021), where she gained experience in data analysis and literature review.

Research Interests

Georgiana’s research interests lie at the intersection of clinical trials, community health, and innovative nursing interventions. Her PhD research investigates the use of music therapy as a tool to combat loneliness — an increasingly relevant public health issue, particularly among older adults. This work reflects her broader interest in psychosocial approaches to nursing care and highlights her dedication to holistic, patient-centered healthcare. In her professional role, she has coordinated numerous cardiology trials, contributing to the development and evaluation of pharmaceutical interventions aimed at improving cardiovascular outcomes. Her past involvement in studies linking nutrition to mental health also shows a multi-disciplinary approach to wellness and disease prevention. Georgiana is particularly drawn to research that translates into actionable clinical practices, bridging the gap between theory and application. She is passionate about advancing the role of nurses in clinical research and believes in empowering nursing professionals through training, mentorship, and scholarly inquiry.

Awards and Honors

While Georgiana Zaharia Hamza is still early in her formal research recognition, her academic and professional journey reflects high achievement and a trajectory worthy of future honors. Her selection as a substitute professor at the University of Valencia is a testament to her academic standing and teaching excellence. She has also earned certifications in internationally recognized training programs such as the ICH-GCP and IATA, underscoring her compliance with global research standards. Though specific awards or honors are not listed in her profile, her extensive responsibilities in high-level clinical research, along with her commitment to educational development and publication efforts, suggest a career on the rise. Her dual engagement in clinical and academic roles positions her as a valuable candidate for prestigious awards like the Women Researcher Award. As she continues to publish, lead studies, and contribute to community health innovation, she is poised to receive formal recognition for her significant contributions to healthcare and research.

Conclusion

Georgiana Zaharia Hamza is a strong candidate for the Women Researcher Award, particularly given her contributions to clinical trials, innovative community-focused PhD research, and teaching in the healthcare field. Her multidimensional experience bridges clinical practice and academic research, making her a standout professional in the nursing and clinical research domains.

Publications Top Notes

Title: The Long-Lasting Effect of Multidisciplinary Interventions for Emotional and Social Loneliness in Older Community-Dwelling Individuals: A Systematic Review
Authors: Georgiana Zaharia, Vanessa Ibáñez-del Valle, Omar Cauli, Silvia Corchon
Year: 2024
Citation: Zaharia, G., Ibáñez-del Valle, V., Cauli, O., & Corchon, S. (2024). The Long-Lasting Effect of Multidisciplinary Interventions for Emotional and Social Loneliness in Older Community-Dwelling Individuals: A Systematic Review. Nursing Reports, 14(4). https://doi.org/10.3390/nursrep14040281

Title: Risk Factors and Prognostic Impact of Unwanted Loneliness in Heart Failure
Authors: Teresa Benito, Georgiana Zaharia, Adora Pérez, Cristina Jaramillo, Miguel Lorenzo, Anna Mollar, Carolina Martínez, Evelin Bejarano, Francisco Cebrián, Jose Civera, et al.
Year: 2024
Citation: Benito, T., Zaharia, G., Pérez, A., Jaramillo, C., Lorenzo, M., Mollar, A., et al. (2024). Risk Factors and Prognostic Impact of Unwanted Loneliness in Heart Failure. Scientific Reports. https://doi.org/10.1038/s41598-024-72847-5

Title: Efficacy and Safety of Bempedoic Acid in Acute Coronary Syndrome. Design of the Clinical Trial ES-BempeDACS
Authors: Sergio Raposeiras-Roubín, Emad Abu-Assi, José Ángel Pérez Rivera, Pablo Jorge Pérez, Ana Ayesta López, Ana Viana Tejedor, Miguel José Corbí Pascual, Anna Carrasquer, César Jiménez Méndez, Cristina González Cambeiro, Georgiana Zaharia, et al.
Year: 2024
Citation: Raposeiras-Roubín, S., Abu-Assi, E., Pérez Rivera, J. Á., Jorge Pérez, P., Ayesta López, A., et al. (2024). Efficacy and Safety of Bempedoic Acid in Acute Coronary Syndrome. Design of the Clinical Trial ES-BempeDACS. Revista Española de Cardiología (English Edition), 77(7). https://doi.org/10.1016/j.rec.2024.05.017

Title: Carbohydrate Antigen 125-Guided Pre-TAVI Medical Optimization: Impact on Quality of Life and Clinical Outcomes
Authors: Sergio García-Blas, Vicente Pernias, Jessika González D’gregorio, Agustín Fernández-Cisnal, Clara Bonanad, Clara Sastre, Ernesto Valero, Gema Miñana, Georgiana Zaharia, Julio Núñez, et al.
Year: 2024
Citation: García-Blas, S., Pernias, V., González D’gregorio, J., Fernández-Cisnal, A., Bonanad, C., et al. (2024). Carbohydrate Antigen 125-Guided Pre-TAVI Medical Optimization: Impact on Quality of Life and Clinical Outcomes. Revista Española de Cardiología (English Edition), 77(2). https://doi.org/10.1016/j.rec.2024.01.002

Title: Social and Emotional Loneliness in Older Community Dwelling-Individuals: The Role of Socio-Demographics
Authors: Vanessa Ibáñez-del Valle, Silvia Corchon, Georgiana Zaharia, Omar Cauli
Year: 2022
Citation: Ibáñez-del Valle, V., Corchon, S., Zaharia, G., & Cauli, O. (2022). Social and Emotional Loneliness in Older Community Dwelling-Individuals: The Role of Socio-Demographics. International Journal of Environmental Research and Public Health, 19(24), 16622. https://doi.org/10.3390/ijerph192416622

Robert Clarke | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Robert Clarke | Medicine and Dentistry | Best Researcher Award

Professor of Epidemiology and Public Health at University of Oxford, United Kingdom

Professor Robert Clarke is a distinguished epidemiologist and public health expert with over three decades of experience in cardiovascular research. He is a Professor of Epidemiology and Public Health Medicine at the University of Oxford and has played a key role in large-scale population health studies. His research has significantly contributed to understanding the genetic and environmental risk factors for cardiovascular diseases. He has been a pivotal figure in several major epidemiological studies, including the China Kadoorie Biobank and the Whitehall Study. In addition to his research, he is an educator, mentoring graduate students and directing the MSc in Global Health Science. His extensive publication record in high-impact journals highlights his influence in shaping global health policies. With a commitment to advancing medical knowledge, he continues to lead groundbreaking studies that inform clinical and public health practices worldwide.

Professional Profile

Education

Professor Clarke holds multiple prestigious degrees and certifications in medicine and public health. He obtained his MB, BCh, BAO from the National University of Ireland in 1979, followed by an MD in 1991. He further enhanced his expertise by earning a Master’s in Science (MSc) from the London School of Hygiene & Tropical Medicine in 1993. His professional qualifications include Membership (MRCP, MRCPI) and Fellowships (FRCP, FFPH, FFPHI) from the Royal Colleges of Physicians in both the UK and Ireland. These qualifications reflect his dedication to clinical and public health research. His advanced education in epidemiology and population health provided the foundation for his groundbreaking contributions to global health science. His training across multiple prestigious institutions has equipped him with the knowledge to conduct rigorous scientific investigations into chronic disease epidemiology, clinical trials, and genetic research.

Professional Experience

Professor Clarke has held multiple influential academic and research positions throughout his career. He has been a faculty member at the University of Oxford since 1991, progressing from Research Fellow to Reader in Epidemiology, and currently serves as a Professor of Epidemiology and Public Health Medicine. Additionally, he has been an Honorary Consultant in Public Health Medicine at the Oxford University Hospitals NHS Trust since 1998. Before joining Oxford, he conducted research at Vanderbilt University (USA) and the Adelaide Hospital (Dublin), focusing on cardiovascular pharmacology. He also serves as the Director of the MSc in Global Health Science at Oxford, overseeing graduate training in epidemiology. His leadership extends to major research collaborations, including steering committees for PROCARDIS, CARDIOGRAMplusC4D, and the China Kadoorie Biobank. Through these roles, he has contributed to shaping public health strategies and advancing evidence-based medicine worldwide.

Research Interests

Professor Clarke’s research focuses on cardiovascular disease epidemiology, genetic risk factors, and the role of nutrition in chronic diseases. He has led numerous large-scale population studies investigating the impact of homocysteine metabolism, B-vitamin supplementation, and omega-3 fatty acids on cardiovascular health. His work has contributed significantly to understanding genetic predisposition to heart disease through genome-wide association studies (GWAS). Additionally, he has been instrumental in evaluating the long-term health effects of diet, cholesterol levels, and blood pressure. His research aims to translate epidemiological findings into clinical interventions that reduce global cardiovascular disease burden. By integrating genetic, biochemical, and lifestyle data, his studies provide critical insights into disease prevention. His research collaborations with international institutions have made significant contributions to global epidemiology, influencing policies related to heart disease prevention and public health nutrition.

Awards and Honors

Professor Clarke has received numerous accolades in recognition of his contributions to epidemiology and public health. His research excellence has earned him Fellowships from the Royal Colleges of Physicians in the UK and Ireland (FRCP, FFPH, FFPHI). He has been an invited member of prestigious scientific advisory committees, including the TILDA Study (Irish Longitudinal Study on Ageing) and the Nutrient Santé Scientific Advisory Committee (France). His work has shaped international guidelines on cardiovascular disease prevention, earning him recognition from leading health organizations. Additionally, his involvement in major clinical trials has positioned him as a key figure in evidence-based medicine. With over three decades of high-impact research and teaching, his contributions continue to be celebrated within the scientific and medical communities, solidifying his reputation as a leader in epidemiology and public health.

Conclusion

Professor Robert Clarke is a highly suitable candidate for the Best Researcher Award. His extensive contributions to epidemiology, cardiovascular research, and large-scale population health studies make him a distinguished figure in the field. His leadership, collaborative efforts, and impactful publications further solidify his reputation. Minor improvements in public engagement and translational research could enhance his profile even further. Overall, he is an exceptionally strong contender for this award.

Publications Top Noted

  • Author: Clarke, R., Du, H., Kurmi, O., Parish, S., Yang, M., Arnold, M., Guo, Y., Bian, Z., Wang, L., Chen, Y., et al.

  • Year: 2017

  • Title: Burden of carotid artery atherosclerosis in Chinese adults: Implications for future risk of cardiovascular diseases

  • Journal: European Journal of Preventive Cardiology

  • Volume & Issue: 24(8)

  • Pages: 900–912

  • DOI: 10.1177/2047487317689973

  • PMID: 28128654

  • Source: Robert Clarke via Europe PubMed Central

 

Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at University of KwaZulu-Natal, South Africa

Professor Nceba Gqaleni is a renowned academic and researcher at the University of KwaZulu-Natal, South Africa. He currently serves as an Acting Academic Leader in the Discipline of Traditional Medicine and as a Research Professor. With a passion for integrating traditional medicine into mainstream healthcare, his research aims to address health challenges facing Africa, including HIV, diabetes, and cancer. His work on herbal treatments and immunomodulators has positioned him as a pioneer in exploring alternative therapies. Prof. Gqaleni’s research is characterized by the synergy between modern science and indigenous knowledge systems, contributing significantly to the global healthcare landscape. His work continues to impact public health, with ongoing clinical trials and innovative studies aimed at improving health outcomes. Additionally, he is committed to training the next generation of researchers, having mentored numerous postdoctoral, PhD, and master’s students.

Professional Profile

Education

Professor Nceba Gqaleni’s educational background is rooted in biochemistry, with a PhD in Biochemistry from the University of Strathclyde in Glasgow, UK. He also holds a Master’s degree in Biochemistry from the University of KwaZulu-Natal (UKZN), South Africa. His academic journey has been marked by a deep interest in both the molecular and traditional aspects of medicine, leading him to pursue research that bridges these fields. His formal education laid the foundation for a distinguished career in both academia and research, where he has applied his scientific expertise to explore alternative therapies and the integration of traditional medicine into contemporary health systems. Prof. Gqaleni’s educational path reflects a commitment to advancing knowledge and improving healthcare, particularly in the African context.

Professional Experience

Professor Gqaleni’s professional experience spans academia, research, and leadership. He currently holds the position of Acting Academic Leader in the Discipline of Traditional Medicine at the University of KwaZulu-Natal. His role involves guiding academic initiatives and research in traditional medicine, while also providing leadership in curriculum development and research supervision. In addition to his academic responsibilities, Prof. Gqaleni has led numerous significant research projects, particularly focused on traditional medicine’s role in addressing major health issues such as HIV and diabetes. His extensive work in supervising postgraduate students, including over 7 postdoctoral researchers, 12 PhD candidates, and 25 master’s students, demonstrates his dedication to nurturing the next generation of scholars and researchers. Prof. Gqaleni’s professional experience is a blend of academic excellence, mentorship, and groundbreaking research in the field of traditional medicine and biochemistry.

Research Interests

Professor Nceba Gqaleni’s research interests lie at the intersection of biochemistry and traditional medicine, with a primary focus on finding alternative treatments for diseases prevalent in Africa, such as HIV, diabetes, and cancer. He has led pioneering research on herbal compositions for the treatment of HIV and is currently conducting clinical trials for a patented HIV cure. In addition to HIV, his research extends to cancer therapies, immunomodulators, and the application of Indigenous phytotherapy in managing diseases like diabetes and HIV. Prof. Gqaleni’s ongoing research projects also explore the health and wellness of Indigenous peoples, particularly in the context of climate change and global health disparities. His work is driven by the goal of bridging the gap between traditional healing practices and modern medical approaches, thereby improving health outcomes in African communities and globally.

Awards and Honors

Professor Nceba Gqaleni’s career has been marked by significant achievements and recognition. He has been honored for his pioneering work in traditional medicine and biochemistry, particularly in the field of HIV and diabetes treatment. One of his notable accomplishments is the filing of a patent for a herbal composition aimed at curing HIV, which is currently undergoing clinical trials. Prof. Gqaleni has also received substantial funding for his research, including a $4.4 million NIH grant for a study on Indigenous phytotherapy. His contributions to science and public health have earned him the respect of both academic and medical communities. Prof. Gqaleni’s work in advancing the integration of traditional medicine into global health systems continues to garner international attention and recognition. His awards and honors reflect his exceptional leadership and groundbreaking contributions to healthcare research.

Conclusion

Professor Nceba Gqaleni demonstrates exceptional potential for the Best Researcher Award due to his innovative contributions to HIV treatment, integration of traditional medicine, and impactful mentorship. His work addresses critical health challenges in Africa, blending traditional knowledge with modern scientific methods. While broader dissemination and commercialization efforts could strengthen his profile, his contributions make him a strong contender for the award.

Publications Top Noted

  • Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective
    • Authors: Frimpong, E.K., Thembane, N., Hlatshwayo, S., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 2
  • Review on the Anti-Hyperglycemic Potential of Psidium guajava and Seriphium plumosum L.
    • Authors: Thembane, N., Hlatshwayo, S., Ngcobo, M., Ngubane, P., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Erratum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 0
  • An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Analysis of Three Species of Cassipourea Traditionally Used for Hypermelanosis in Selected Provinces in South Africa
    • Authors: Mpofana, N., Yalo, M., Gqaleni, N., Dlova, N.C., Hussein, A.A.
    • Year: 2024
    • Citations: 0
  • Melasma in People with Darker Skin Types: A Scoping Review Protocol on Prevalence, Treatment Options for Melasma, and Impact on Quality of Life
    • Authors: Mpofana, N., Chibi, B., Gqaleni, N., Kgarosi, K., Dlova, N.C.
    • Year: 2023
    • Citations: 3
  • The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
    • Authors: Mpofana, N., Paulse, M., Gqaleni, N., Hussein, A., Dlova, N.C.
    • Year: 2023
    • Citations: 0
  • The Met and Unmet Health Needs for HIV, Hypertension, and Diabetes in Rural KwaZulu-Natal, South Africa: Analysis of a Cross-Sectional Multimorbidity Survey
    • Authors: Singh, U., Olivier, S., Cuadros, D., Ramnanan, A., Harilall, S., Gqaleni, N.
    • Year: 2023
    • Citations: 5
  • An Investigation into the Acute and Subacute Toxicity of Extracts of Cassipourea flanaganii Stem Bark In Vivo
    • Authors: Mpofana, N., Chipangura, J.K., Paulse, M., Hussein, A.A., Crouch, N.R.
    • Year: 2023
    • Citations: 2
  • Treatment of Melasma on Darker Skin Types: A Scoping Review
    • Authors: Mpofana, N., Chibi, B., Visser, T., Hussein, A.A., Dlova, N.C.
    • Year: 2023
    • Citations: 4